We are a professional team: 90% of our members have bachelor degree or above, and have many years of professional technical background in pharmaceutical chemistry. The team management personnel are all senior personnel in the pharmaceutical industry, with more than 15 years of experience in the industry. 

We are a struggling team: our average age is 32 years old, and we are in the stage of vigorous and hard-working.

We are a dedicated team: innovative drug development is a difficult and long sacred undertaking, and we firmly believe that only focus can lead to success

At present, the main research direction of the company is the 1.1 class of innovative drugs for neurodegenerative diseases. Indications that have been declared for international patents include Alzheimer's disease, Parkinson's disease and glaucoma. Three patent groups have been formed, and experimental data are being collected for five indications to be declared